These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26039660)

  • 21. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
    Sentí M; Tomás M; Marrugat J; Elosua R;
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
    Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
    Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipase C, Hepatic Type -250A/G (rs2070895) Variant Enhances Carotid Atherosclerosis in Normolipidemic and Asymptomatic Individuals from Brazil.
    Zago VHS; Parra ES; Virgínio VWM; Vendrame F; Gomes ÉIL; Scherrer DZ; Marson FAL; de Faria EC
    Lipids; 2020 May; 55(3):225-237. PubMed ID: 32196671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between high density lipoprotein antioxidant activity and carotid arterial intima-media thickness in patients with essential hypertension.
    Chen X; Wu Y; Liu L; Su Y; Peng Y; Jiang L; Liu X; Huang D
    Clin Exp Hypertens; 2010 Jan; 32(1):13-20. PubMed ID: 20144068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.
    Kamal M; Fathy MM; Taher E; Hasan M; Tolba M
    Ann Saudi Med; 2011; 31(5):481-7. PubMed ID: 21911985
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Ragkousis A; Kazantzis D; Georgalas I; Theodossiadis P; Kroupis C; Chatziralli I
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraoxonase 1 (PON1) Q192R Gene Polymorphism and Cancer Risk: A Meta-Analysis Based on 30 Publications.
    Zhang M; Xiong H; Fang L; Lu W; Wu X; Huang ZS; Wang YQ; Cai ZM; Wu S
    Asian Pac J Cancer Prev; 2015; 16(10):4457-63. PubMed ID: 26028114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.
    Souza-Nogueira A; Camargo AE; Remondi FA; Paoliello MM; Richter RJ; Furlong CE; Barbosa DS; Maes M; Moreira EG
    Arch Endocrinol Metab; 2016 Oct; 60(5):426-435. PubMed ID: 27812605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes.
    Mahrooz A; Alizadeh A; Gohari G
    J Neurol Sci; 2014 Mar; 338(1-2):197-202. PubMed ID: 24433930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
    Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
    Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
    Saeed SA; Elsharkawy M; Elsaeed K; Fooda O
    Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain.
    Garcés C; López-Simón L; Rubio R; Benavente M; Cano B; Ortega H; de Oya M
    Clin Chem Lab Med; 2008; 46(6):809-13. PubMed ID: 18601602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
    Viktorinova A; Svitekova K; Stecova A; Krizko M
    Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Paraoxonase 1 Gene c.-108C>T SNP in the Promoter Is Associated with Risk for Glioma in Mexican Patients, but Not the p.L55M or p.Q192R Polymorphisms in the Coding Region.
    González-Herrera L; Gamas-Trujillo PA; Medina-Escobedo G; Oaxaca-Castillo D; Pérez-Mendoza G; Williams-Jacquez D; Canto-Cetina T; Vargas-García RD
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):494-9. PubMed ID: 26154629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects.
    Hassan MA; Al-Attas OS; Hussain T; Al-Daghri NM; Alokail MS; Mohammed AK; Vinodson B
    Mol Cell Biochem; 2013 Aug; 380(1-2):121-8. PubMed ID: 23625196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase-1 (PON1) activity, but not PON1(Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population.
    Kotur-Stevuljevic J; Spasic S; Stefanovic A; Zeljkovic A; Bogavac-Stanojevic N; Kalimanovska-Ostric D; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z
    Clin Chem Lab Med; 2006; 44(10):1206-13. PubMed ID: 17032132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men.
    Malin R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Pasanen M; Oja P; Bond G; Koivula T; Lehtimäki T
    Metabolism; 2001 Sep; 50(9):1095-101. PubMed ID: 11555845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
    J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.